After recalibrating its production strategy in the late 2010s to help meet the realities of the CAR-T market, Gilead Sciences’ Kite Pharma is preparing to hit the ground running with the potential approval of a next-generation multiple myeloma cell therapy later this year.
With ‘lessons learned,’ Kite prepares to hit the ground running as next-gen CAR-T decision looms
Latest from Blog
Why Coconut Flour May Be The Very Thing Your Baking Projects Need
Coconut flour is gluten-free and has a delicious natural sweetness, allowing you to use less sweetener in your baking. Post Views: 2
School nutrition programs face funding challenges as costs outpace federal reimbursements
The National School Nutrition Association says 98% of its member school nutrition directors across the country reported food cost challenges. Post Views: 1
Learning outcomes and child health are linked
In early childhood, nutrition and development outcomes depend critically on the quality of care children receive Post Views: 2
NATSINPAS: National Aboriginal and Torres Strait Islander Nutrition and Physical Activity Survey Data Released
ABS releases NATSINPAS microdata from 2023 and 2012-13 cycles, covering nutrition, physical activity, sedentary behaviour, and sleep. Includes basic and detailed microdata, accelerometer outputs, and weight variables for population estimates. Post Views:
“The way we fuel has completely changed”: Pavel Sivakov details the extreme nutrition of modern cycling at UAE Team Emirates
After spending his early professional career with the Team Sky/Ineos setup, Pavel Sivakov made the jump to UAE Team Emirates – XRG in 2024. While he has adapted well to the Emirati